Стр. 165 - 2

158. Gately MK. Interleukin-12: potential clinical applications in the treatment of
chronic viral hepatitis / M.K. Gately // J. Viral. Hepat. - 1997.- Suppl. 1. - P. 33-
39.
159. Geneva-Popova M. Study on proinflammatory cytokines (IL-1 beta, IL-6,
TNF-alpha) and IL-2 in patients with acute hepatitis B / M. Geneva-Popova, M.
Murdjeva // Folia. Med. (Plovdiv). - 1999. - Vol.41,№1. - Р. 78-81.
160. Ghendon Y. Z. World health organization strategy for control of hepatitis B.-
In: Control of virus disease. Ed. E. Kurstak 2d ed. Marcel Dekker Inc., N-Y.,
1993, P. 141-164.
161. Guidotti L.G. Cytokine mediated control of viral infections / L.G. Guidotti,
F.V. Chisari// Virology. - 2000. - Vol. 273. - P. 221-227.
162. Guidotti L.G. The role of cytotoxic T cells and cytokines in the control of
hepatitis B virus infection / L.G. Guidotti // Vaccine. – 2002. - Vol.20, Suppl 4. -
P. 80-82.
163. HBcAg-specific cytokine production by CD4 T lymphocytes of children with
acute and chronic hepatitis B / A. Szkaradkiewicz, A. Jopek, J. Wysocki et al. //
Virus Res.- 2003. - Vol.97,№2. - Р. 127-133.
164. HBV-specific lymphoproliferative and cytokine responses in patients with
chronic hepatitis B / J.Vingerhoets, P. Michielsen, G. Vanham // J. Hepatol. -
1998. -Vol.28,№1. - Р. 8-16.
165. Hepatitis B core antigen is a potent inductor of interleukin-18 in peripheral
blood mononuclear cells of healthy controls and patients with hepatitis B infection
/ T. Manigold, U. Bocker, J. Chen et al. // J. Med. Virol. - 2003. - Vol.71,№1. - Р.
31-40.
166. Hepatitis B surface antigenemia at birth: A long term follow-up study / J.
Tang, H.Y. Hsu, H.H. Lin et al. // J. Pediatr. - 1998. - Vol. 133. - P. 374-377.